BBLG Q1 2024 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$903,536

Net Income

-$865,970

EPS (Diluted)

$-1.31

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$52,681

Balance Sheet

Total Assets

$4M

Total Liabilities

$164,626

Stockholders' Equity

$4M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$903,536	-$3M	+71.3%
Net Income	-$865,970	-$4M	+76.7%